Case-Based Roundtable
General Dermatology
Eczema
Chronic Hand Eczema
Chronic Spontaneous Urticaria
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis
Buy-and-Bill

Article

February 1, 2003

Progressive Systemic Sclerosis

Paris - Researchers at Jefferson Medical College are developing cutting edge techniques to attack the increased biosynthesis that appears to cause accumulation of collagen characteristic of scleroderma and particularly of a subset of the disease known as progressive systemic sclerosis (PSS), Jouni Uitto, M.D., Ph.D., chair, department of dermatology and cutaneous biology, said here at the World Congress of Dermatology.

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!